Sangamo Biosciences (SGMO) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Research and development: 17.01M
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Sangamo Biosciences (NASDAQ: SGMO) reported Q2 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $14.72 million.
For earnings history and earnings-related data on Sangamo Biosciences (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
- Star Equity Holdings (STRR) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
